A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Progress in targeting cell envelope biogenesis inMycobacterium tuberculosis
2013
Future Microbiology
Most of the newly discovered compounds showing promise for the treatment of TB, notably multidrug-resistant TB, inhibit aspects of Mycobacterium tuberculosis cell envelope metabolism. This review reflects on the evolution of the knowledge that many of the front-line and emerging products inhibit aspects of cell envelope metabolism and in the process are bactericidal not only against actively replicating M. tuberculosis, but contrary to earlier impressions, are effective against latent forms of
doi:10.2217/fmb.13.52
pmid:23841633
pmcid:PMC3867987
fatcat:mwtudhltyreb7bsnxnk537lr2e